KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Acquisitions (2016 - 2025)

Cvs Health (CVS) has disclosed Acquisitions for 17 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Acquisitions fell 30.0% year-over-year to $7.0 million, compared with a TTM value of $436.0 million through Dec 2025, up 358.95%, and an annual FY2025 reading of $436.0 million, up 358.95% over the prior year.
  • Acquisitions was $7.0 million for Q4 2025 at Cvs Health, down from $290.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $9.4 billion in Q2 2023 and bottomed at $6.0 million in Q3 2022.
  • Average Acquisitions over 5 years is $871.4 million, with a median of $24.5 million recorded in 2021.
  • The sharpest move saw Acquisitions soared 101242.86% in 2023, then tumbled 99.65% in 2024.
  • Year by year, Acquisitions stood at $11.0 million in 2021, then dropped by 27.27% to $8.0 million in 2022, then skyrocketed by 1400.0% to $120.0 million in 2023, then crashed by 91.67% to $10.0 million in 2024, then decreased by 30.0% to $7.0 million in 2025.
  • Business Quant data shows Acquisitions for CVS at $7.0 million in Q4 2025, $290.0 million in Q3 2025, and $119.0 million in Q2 2025.